Comparative Effectiveness of Ampicillin/Sulbactam versus Cefazolin as Targeted Therapy for Bacteremia Caused by Beta-Lactamase-Producing Methicillin-Sensitive <i>Staphylococcus aureus</i>: A Single-Center Retrospective Study

• Main Authors: Jun Hirai (Author), Nobuhiro Asai (Author), Mao Hagihara (Author), Takaaki Kishino (Author), Hideo Kato (Author), Daisuke Sakanashi (Author), Wataru Ohashi (Author), Hiroshige Mikamo (Author)
• Format: Book
• Published: MDPI AG, 2022-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Cefazolin (CFZ) is the first-line treatment for beta-lactamase-producing methicillin-sensitive <i>Staphylococcus aureus</i> (BP-MSSA) infection. In 2019, Japan experienced a CFZ shortage because of foreign object inclusion in a batch. Ampicillin/sulbactam (SAM) was preferred in many case...